Volume 27, Number 3—March 2021
Addressing Reemergence of Diphtheria among Adolescents through Program Integration in India
|Diphtheria vaccine||Based on card information only, no. (%)||Based on card information or parental recall, no. (%)|
|Pentavalent 1 or DTP1||23 (23)||55 (56)|
|Pentavalent 2 or DTP2||23 (23)||53 (54)|
|Pentavalent 3 or DTP3||23 (23)||52 (53)|
|DTP booster 1||21 (21)||44 (44)|
|DTP booster 2†||17 (18)||35 (36)|
*DTP, diphtheria-tetanus-pertussis vaccine. †Denominator for DTP booster 2 = 96; three 4-year-olds were excluded because they were not eligible for DTP booster 2 based on age.
Page created: December 22, 2020
Page updated: February 21, 2021
Page reviewed: February 21, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.